AUROBINDO PHARMA LTD FDA Approval ANDA 212775

ANDA 212775

AUROBINDO PHARMA LTD

FDA Drug Application

Application #212775

Application Sponsors

ANDA 212775AUROBINDO PHARMA LTD

Marketing Status

Prescription001

Application Products

001SPRAY, METERED;NASALEQ 0.1876MG BASE/SPRAY0AZELASTINE HYDROCHLORIDEAZELASTINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-11-12STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212775
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZELASTINE HYDROCHLORIDE","activeIngredients":"AZELASTINE HYDROCHLORIDE","strength":"EQ 0.1876MG BASE\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/12\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-11-12
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.